Literature DB >> 18950333

End-of-life decisions in pediatric intensive care. Recommendations of the Italian Society of Neonatal and Pediatric Anesthesia and Intensive Care (SARNePI).

Alberto Giannini1, Andrea Messeri, Anna Aprile, Carlo Casalone, Momcilo Jankovic, Roberto Scarani, Corrado Viafora.   

Abstract

End-of-life decisions represent one of the most complex and challenging issues in pediatric intensive care. These recommendations aim to offer Italian pediatric intensive care unit (PICU) teams a framework for the end-of-life decision-making process. The paper proposes a process based on the principle that the use of a diagnostic or therapeutic tool must comply with a 'criterion of proportionality'. Appropriately informed parents, as natural interpreters and advocates of the best interests of their child, can contribute in assessing the burdensomeness of the treatment and determining its proportionality. The decision to limit, withdraw or withhold life-sustaining treatments considered disproportionate represents a clinically and ethically correct choice. This decision should be made (a) collectively by PICU team and the other caregivers, (b) with the explicit involvement of parents, and (c) noting in the patient's clinical record the decisions taken and the reasons behind them. The withdrawing or withholding of life support can never entail the abandonment of the patient nor the withdrawal of any therapy aimed at treating any form of suffering. No action aimed at deliberately hastening the death of the patient is ever acceptable. These recommendations advocate a decision as far as possible shared by patient (whenever feasible), parents and caregivers. Ensuring that all involved are kept fully informed and that there is open and timely communication between them is the key to achieving this. It is the physician in charge of the patient's care and the head of the unit who bear the main responsibility for the final decision.

Entities:  

Mesh:

Year:  2008        PMID: 18950333     DOI: 10.1111/j.1460-9592.2008.02777.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  7 in total

1.  Shared decision-making in pediatric intensive care units: a qualitative study with physicians, nurses and parents.

Authors:  Rabia Kahveci; Duygu Ayhan; Pınar Döner; Fatma Gökşin Cihan; Esra Meltem Koç
Journal:  Indian J Pediatr       Date:  2014-04-22       Impact factor: 1.967

2.  Decision making for life sustaining therapies in pediatric intensive care: who should decide?

Authors:  Praveen Khilnani
Journal:  Indian J Pediatr       Date:  2014-11-12       Impact factor: 1.967

Review 3.  Parental decision-making for medically complex infants and children: an integrated literature review.

Authors:  Kimberly A Allen
Journal:  Int J Nurs Stud       Date:  2014-02-20       Impact factor: 5.837

4.  Forgoing life support: how the decision is made in European pediatric intensive care units.

Authors:  Denis J Devictor; Jos M Latour
Journal:  Intensive Care Med       Date:  2011-10-01       Impact factor: 17.440

5.  The Motion of the Italian National Bioethics Committee on Aggressive Treatment towards Children with Limited Life Expectancy.

Authors:  Matteo Bolcato; Marianna Russo; Alessandro Feola; Bruno Della Pietra; Camilla Tettamanti; Alessandro Bonsignore; Rosagemma Ciliberti; Daniele Rodriguez; Anna Aprile
Journal:  Healthcare (Basel)       Date:  2020-11-01

6.  Life-sustaining treatment decisions in pediatric intensive care: an Italian survey on ethical concerns.

Authors:  Franco A Carnevale; Alberto Giannini; Amabile Bonaldi; Elena Bravi; Costanza Cecchi; Andrea Pettenazzo; Angela Amigoni; Silvia Maria Modesta Pulitanò; Chiara Tosin; Paolo Biban
Journal:  Ital J Pediatr       Date:  2021-07-07       Impact factor: 2.638

7.  Analyzing the paradigmatic cases of two persons with a disorder of consciousness: reflections on the legal and ethical perspectives.

Authors:  Mario Picozzi; Lino Panzeri; Davide Torri; Davide Sattin
Journal:  BMC Med Ethics       Date:  2021-07-08       Impact factor: 2.652

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.